Significance of local treatment in patients with metastatic soft tissue sarcoma

American Journal of Cancer Research

Volumn 5, Issue 6, 2015, Pages 2075-2082

  Jiang, Long ^a,b,c   Jiang, Shanshan ^a,b   Lin, Yongbin ^a,b   Situ, Dongrong ^a,b   Yang, Han ^a,b   Li, Yuanfang ^a,b   Long, Hao ^a,b   Zhou, Zhiwei ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b Department of Colorectal Surgery   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Local treatment; Metastasis; Prognosis; Soft tissue sarcoma

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURGERY; CHILD; CLINICAL EFFECTIVENESS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTATIC SOFT TISSUE SARCOMA; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; RADIOFREQUENCY ABLATION; SOFT TISSUE SARCOMA; TREATMENT INDICATION;

EID: 85006197320     PISSN: None     EISSN: 21566976     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Siegel R, Ma J, Zou Z and Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9-29.
2. Ludwig JA. Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future. Curr Opin Oncol 2008; 20: 412-418.
3. Cotterill SJ, Ahrens S, Paulussen M, Jurgens HF, Voute PA, Gadner H and Craft AW. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol 2000; 18: 3108-3114.
4. Subbiah V, Anderson P, Lazar AJ, Burdett E, Raymond K and Ludwig JA. Ewing's sarcoma:standard and experimental treatment options. Curr Treat Options Oncol 2009; 10: 126-140.
5. Corey RM, Swett K and Ward WG. Epidemiology and survivorship of soft tissue sarcomas in adults: a national cancer database report. Cancer Med 2014; 3: 1404-1415.
6. Tsuchiya H, Kanazawa Y, Abdel-Wanis ME, Asada N, Abe S, Isu K, Sugita T and Tomita K. Effect of timing of pulmonary metastases identification on prognosis of patients with osteosarcoma:the Japanese Musculoskeletal Oncology Group study. J Clin Oncol 2002; 20:3470-3477.
7. Briccoli A, Rocca M, Salone M, Bacci G, Ferrari S, Balladelli A and Mercuri M. Resection of recurrent pulmonary metastases in patients with osteosarcoma. Cancer 2005; 104: 1721-1725.
8. Kempf-Bielack B, Bielack SS, Jurgens H, Branscheid D, Berdel WE, Exner GU, Gobel U, Helmke K, Jundt G, Kabisch H, Kevric M, Klingebiel T, Kotz R, Maas R, Schwarz R, Semik M, Treuner J, Zoubek A and Winkler K. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). J Clin Oncol 2005; 23: 559-568.
9. Carter SR, Grimer RJ, Sneath RS and Matthews HR. Results of thoracotomy in osteogenic sarcoma with pulmonary metastases. Thorax 1991; 46: 727-731.
10. DeMatteo RP, Shah A, Fong Y, Jarnagin WR, Blumgart LH and Brennan MF. Results of hepatic resection for sarcoma metastatic to liver. Ann Surg 2001; 234: 540-548.
11. Bauer S and Hartmann JT. Locally advanced and metastatic sarcoma (adult type) including gastrointestinal stromal tumors. Crit Rev Oncol Hematol 2006; 60: 112-130.
12. Abdalla EK and Pisters PW. Metastasectomy for limited metastases from soft tissue sarcoma. Curr Treat Options Oncol 2002; 3: 497-505.
13. Bacci G, Mercuri M, Briccoli A, Ferrari S, Bertoni F, Donati D, Monti C, Zanoni A, Forni C and Manfrini M. Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions. Cancer 1997; 79: 245-254.
14. Snyder CL, Saltzman DA, Ferrell KL, Thompson RC and Leonard AS. A new approach to the resection of pulmonary osteosarcoma metastases. Results of aggressive metastasectomy. Clin Orthop Relat Res 1991; 247-253.
15. Pisters PW, O'Sullivan B and Maki RG. Evidence- based recommendations for local therapy for soft tissue sarcomas. J Clin Oncol 2007; 25: 1003-1008.
16. Prosnitz LR, Maguire P, Anderson JM, Scully SP, Harrelson JM, Jones EL, Dewhirst M, Samulski TV, Powers BE, Rosner GL, Dodge RK, Layfield L, Clough R and Brizel DM. The treatment of high-grade soft tissue sarcomas with preoper ative thermoradiotherapy. Int J Radiat Oncol Biol Phys 1999; 45: 941-949.
17. Blakely ML, Spurbeck WW, Pappo AS, Pratt CB, Rodriguez-Galindo C, Santana VM, Merchant TE, Prichard M and Rao BN. The impact of margin of resection on outcome in pediatric nonrhabdomyosarcoma soft tissue sarcoma. J Pediatr Surg 1999; 34: 672-675.
18. Dupuy DE, Zagoria RJ, Akerley W, Mayo-Smith WW, Kavanagh PV and Safran H. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol 2000; 174: 57-59.
19. Suh RD, Wallace AB, Sheehan RE, Heinze SB and Goldin JG. Unresectable pulmonary malignancies:CT-guided percutaneous radiofrequency ablation--preliminary results. Radiology 2003; 229: 821-829.
20. Akeboshi M, Yamakado K, Nakatsuka A, Hataji O, Taguchi O, Takao M and Takeda K. Percutaneous radiofrequency ablation of lung neoplasms:initial therapeutic response. J Vasc Interv Radiol 2004; 15: 463-470.
21. Nakamura T, Matsumine A, Yamakado K, Matsubara T, Takaki H, Nakatsuka A, Takeda K, Abo D, Shimizu T and Uchida A. Lung radiofrequency ablation in patients with pulmonary metastases from musculoskeletal sarcomas [corrected]. Cancer 2009; 115: 3774-3781.
22. Ferrari A, Dileo P, Casanova M, Bertulli R, Meazza C, Gandola L, Navarria P, Collini P, Gronchi A, Olmi P, Fossati-Bellani F and Casali PG. Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution. Cancer 2003;8:71-580.
23. Rosenberg AE. WHO Classification of Soft Tissue and Bone, fourth edition: summary and commentary. Curr Opin Oncol 2013; 25: 571-573.
24. Martin-Ponce E, Hernandez-Betancor I, Gonzalez-Reimers E, Hernandez-Luis R, Martinez-Riera A and Santolaria F. Prognostic value of physical function tests: hand grip strength and six-minute walking test in elderly hospitalized patients. Sci Rep 2014; 4: 7530.
25. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D and Verweij J. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-247.
26. Breneman JC, Lyden E, Pappo AS, Link MP, Anderson JR, Parham DM, Qualman SJ, Wharam MD, Donaldson SS, Maurer HM, Meyer WH, Baker KS, Paidas CN and Crist WM. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma-- a report from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 2003; 21: 78-84.
27. Rodeberg D, Arndt C, Breneman J, Lyden E, Donaldson S, Paidas C, Andrassy R, Meyer W and Wiener E. Characteristics and outcomes of rhabdomyosarcoma patients with isolated lung metastases from IRS-IV. J Pediatr Surg 2005; 40: 256-262.
28. Carli M, Colombatti R, Oberlin O, Bisogno G, Treuner J, Koscielniak E, Tridello G, Garaventa A, Pinkerton R and Stevens M. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors. J Clin Oncol 2004; 22: 4787-4794.
29. Crist W, Gehan EA, Ragab AH, Dickman PS, Donaldson SS, Fryer C, Hammond D, Hays DM, Herrmann J, Heyn R and Et A. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 1995; 13: 610-630.
30. Koscielniak E, Harms D, Henze G, Jurgens H, Gadner H, Herbst M, Klingebiel T, Schmidt BF, Morgan M, Knietig R and Treuner J. Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. J Clin Oncol 1999; 17: 3706-3719.
31. Karnak I, Emin SM, Kutluk T, Tanyel FC and Buyukpamukcu N. Pulmonary metastases in children: an analysis of surgical spectrum. Eur J Pediatr Surg 2002; 12: 151-158.
32. Kandioler D, Kromer E, Tuchler H, End A, Muller MR, Wolner E and Eckersberger F. Long-term results after repeated surgical removal of pulmonary metastases. Ann Thorac Surg 1998; 65: 909-912.
33. Gadd MA, Casper ES, Woodruff JM, McCormack PM and Brennan MF. Development and treatment of pulmonary metastases in adult patients with extremity soft tissue sarcoma. Ann Surg 1993; 218: 705-712.
34. Rehders A, Hosch SB, Scheunemann P, Stoecklein NH, Knoefel WT and Peiper M. Benefit of surgical treatment of lung metastasis in soft tissue sarcoma. Arch Surg 2007; 142: 70-76.
35. Weiser MR, Downey RJ, Leung DH and Brennan MF. Repeat resection of pulmonary metastases in patients with soft-tissue sarcoma. J Am Coll Surg 2000; 191: 184-191.
36. Blackmon SH, Shah N, Roth JA, Correa AM, Vaporciyan AA, Rice DC, Hofstetter W, Walsh GL, Benjamin R, Pollock R, Swisher SG and Mehran R. Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival. Ann Thorac Surg 2009; 88: 877-885.
37. Stragliotto CL, Karlsson K, Lax I, Rutkowska E, Bergh J, Strander H, Blomgren H and Friesland S. A retrospective study of SBRT of metastases in patients with primary sarcoma. Med Oncol 2012; 29: 3431-3439.
38. Ding JH, Chua TC, Glenn D and Morris DL. Feasibility of ablation as an alternative to surgical metastasectomy in patients with unresectable sarcoma pulmonary metastases. Interact Cardiovasc Thorac Surg 2009; 9: 1051-1053.
39. von Meyenfeldt EM, Prevoo W, Peyrot D, Lai AFN, Burgers SJ, Wouters MW and Klomp HM. Local progression after radiofrequency ablation for pulmonary metastases. Cancer 2011; 117: 3781-3787.
40. Maurer HM, Beltangady M, Gehan EA, Crist W, Hammond D, Hays DM, Heyn R, Lawrence W, Newton W, Ortega J and Et A. The Intergroup Rhabdomyosarcoma Study-I. A final report. Cancer 1988; 61: 209-220.
41. Dantonello TM, Winkler P, Boelling T, Friedel G, Schmid I, Mattke AC, Ljungman G, Bielack SS, Klingebiel T and Koscielniak E. Embryonal rhabdomyosarcoma with metastases confined to the lungs: report from the CWS Study Group. Pediatr Blood Cancer 2011; 56: 725-732.
42. Raney B, Anderson J, Breneman J, Donaldson SS, Huh W, Maurer H, Michalski J, Qualman S, Ullrich F, Wharam M and Meyer W. Results in patients with cranial parameningeal sarcoma and metastases (Stage 4) treated on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols II-IV, 1978-1997: report from the Children's Oncology Group. Pediatr Blood Cancer 2008; 51: 17-22.
43. Ginsberg RJ, Hill LD, Eagan RT, Thomas P, Mountain CF, Deslauriers J, Fry WA, Butz RO, Goldberg M, Waters PF and Et A. Modern thirtyday operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg 1983; 86: 654-658.
44. Deslauriers J, Ginsberg RJ, Piantadosi S and Fournier B. Prospective assessment of 30-day operative morbidity for surgical resections in lung cancer. Chest 1994; 106: 329S-330S.
45. Osaka S, Sugita H, Osaka E, Yoshida Y and Ryu J. Surgical management of malignant soft tissue tumours in patients aged 65 years or older. J Orthop Surg (Hong Kong) 2003; 11: 28-33.
46. Torigoe T, Terakado A, Suehara Y, Kurosawa H, Yazawa Y and Takagi T. Bone versus soft-tissue sarcomas in the elderly. J Orthop Surg (Hong Kong) 2010; 18: 58-62.